Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Frédéric P. Vanhoutte
Observed names:
F Vanhoutte,
F. Vanhoutte,
F.P. Vanhoutte,
Frederic P. Vanhoutte,
Frederic Vanhoutte,
Frédéric Vanhoutte
show all 6
Institution:
SGS (Belgium)
Observed institutions:
Janssen (Belgium),
Leicester Royal Infirmary,
Groote Schuur Hospital,
Aarhus University Hospital,
Ziekenhuisnetwerk Antwerpen Stuivenberg,
SGS (Belgium),
Galapagos (Belgium)
show all 7
OpenAlex ID:
A5111875619
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
2016
·
R Westhovens
, P C Taylor
, et al.
·
Annals of the Rheumatic Diseases
·
236
PDF
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)
2016
·
A Kavanaugh
, J Kremer
, et al.
·
Annals of the Rheumatic Diseases
·
229
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
2023
·
Douglas G. Johns
, Louis-Charles Campeau
, et al.
·
Circulation
·
172
PDF
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study
2001
·
M. Bhushan
, A.D. Burden
, et al.
·
British Journal of Dermatology
·
126
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK‐1 Inhibitor, After Short‐Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials
2017
·
Frédéric Vanhoutte
, Minodora Mazur
, et al.
·
Arthritis & Rheumatology
·
82
PDF
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers
2019
·
Andi Leubitz
, Anat Frydman‐Marom
, et al.
·
Clinical Pharmacology in Drug Development
·
70
PDF
Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study
2007
·
C.J. Verfaille
, F.P. Vanhoutte
, et al.
·
British Journal of Dermatology
·
64
A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
2016
·
Geert A. Cirkel
, Bojana Milojkovic Kerklaan
, et al.
·
Investigational New Drugs
·
63
PDF
Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects
2016
·
Florence Namour
, René Galien
, et al.
·
British Journal of Clinical Pharmacology
·
55
PDF
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti‐Activin A): Results From a First‐in‐Human Phase 1 Study
2020
·
Frédéric Vanhoutte
, Su Liang
, et al.
·
The Journal of Clinical Pharmacology
·
50
PDF
Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis
2019
·
Elina Berliba
, Maxim Bogus
, et al.
·
Antimicrobial Agents and Chemotherapy
·
47
Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers
2023
·
Oliver Ackaert
, Frédéric Vanhoutte
, et al.
·
Clinical Infectious Diseases
·
45
PDF
Treatment of psoriasis with oral liarozole: a dose‐ranging study
2000
·
J. Berth‐Jones
, G. Todd
, et al.
·
British Journal of Dermatology
·
39
A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects
2021
·
Andi Leubitz
, Frederic Vanhoutte
, et al.
·
Clinical Pharmacology in Drug Development
·
34
PDF
Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study
2005
·
G.P.H. Lucker
, C.J. Verfaille
, et al.
·
British Journal of Dermatology
·
30
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial
2022
·
Frédéric Vanhoutte
, Wen Liu
, et al.
·
EBioMedicine
·
27
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial
2012
·
René Westhovens
, Filip De Keyser
, et al.
·
Annals of the Rheumatic Diseases
·
23
PDF
P610 Efficacy and safety of GLPG1205, a GPR84 antagonist, in ulcerative colitis: multi-centre proof-of-concept study
2017
·
S. Vermeire
, W. Reinisch
, et al.
·
Journal of Crohn s and Colitis
·
18
THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study
2016
·
A. Kavanaugh
, L. Ponce
, et al.
·
Annals of the Rheumatic Diseases
·
16
Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects
2020
·
Christian Funck‐Brentano
, Mathieu Felices
, et al.
·
British Journal of Clinical Pharmacology
·
15
OP0224 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study
2016
·
R. Westhovens
, R. Alten
, et al.
·
Annals of the Rheumatic Diseases
·
14
OP0263 Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial
2012
·
F.P. Vanhoutte
, M. Mazur
, et al.
·
Annals of the Rheumatic Diseases
·
14
Pharmacokinetics, Safety, and Tolerability of GLPG0259, a Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Inhibitor, Given as Single and Multiple Doses to Healthy Male Subjects
2012
·
Florence Namour
, Frédéric P. Vanhoutte
, et al.
·
Drugs in R&D
·
12
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant
2024
·
François Rony
, Mauro Cortellini
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
11
ADAMTS-5 inhibitor GLPG1972, a potential new treatment in osteoarthritis, shows favorable safety, pharmacokinetics and pharmacodynamics in healthy subjects
2018
·
E.M. van der Aar
, J. Desrivot
, et al.
·
Osteoarthritis and Cartilage
·
11
PDF
Show more works
View as search
Works count:
42
Citation count:
1,538
H-index:
18
I10-index:
25
Year
Topic
Type
